Related references
Note: Only part of the references are listed.Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
David P. Nichols et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study
Dominic A. Hughes et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Clinician variability in the diagnosis and treatment of aspergillus fumigatus-related conditions in cystic fibrosis: An international survey
Gina Hong et al.
JOURNAL OF CYSTIC FIBROSIS (2022)
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without Pseudomonas aeruginosa
Jonathan D. Cogen et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2022)
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment
D. R. VanDevanter et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Longitudinal course of clinical lung clearance index in children with cystic fibrosis
Bettina S. Frauchiger et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis
Gina Hong et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis
Jeffrey S. Wagener et al.
PEDIATRIC PULMONOLOGY (2020)
Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
Charlie McLeod et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Change in lung clearance index with microbiological status in children with cystic fibrosis
Katarzyna Walicka-Serzysko et al.
PEDIATRIC PULMONOLOGY (2019)
Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement
Brian L. Graham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis
Patrick A. Flume et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Aspergillus and progression of lung disease in children with cystic fibrosis
Sabariah Noor Harun et al.
THORAX (2019)
Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis
Oded Breuer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory
Francoise Botterel et al.
MYCOPATHOLOGIA (2018)
Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis
Gina Hong et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Use of Selective Fungal Culture Media Increases Rates of Detection of Fungi in the Respiratory Tract of Cystic Fibrosis Patients
Gina Hong et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
Philip M. Farrell et al.
JOURNAL OF PEDIATRICS (2017)
Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center
S. Ziesing et al.
MEDICAL MYCOLOGY (2016)
Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship
M. Noni et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
A Systematic Review of Factors Associated with Health-Related Quality of Life in Adolescents and Adults with Cystic Fibrosis
Al-Rahim R. Habib et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
The Table 2 Fallacy: Presenting and Interpreting Confounder and Modifier Coefficients
Daniel Westreich et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Cystic Fibrosis Transmembrane Conductance Regulator Regulates Epithelial Cell Response to Aspergillus and Resultant Pulmonary Inflammation
Neelkamal Chaudhary et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The Effect of Aspergillus fumigatus Infection on Vitamin D Receptor Expression in Cystic Fibrosis
Catherine A. Coughlan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population
Michelle A. McMahon et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study
Shawn D. Aaron et al.
PLOS ONE (2012)
Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic Fibrosis
Catherine Gangell et al.
CLINICAL INFECTIOUS DISEASES (2011)
Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
A. M. M. de Vrankrijker et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Alan R. Hauser et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium
James A. Reihill et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
Kaissa de Boer et al.
THORAX (2011)
The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
Reshma Amin et al.
CHEST (2010)
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis
Christopher R. Sudfeld et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi
Andrew M. Borman et al.
MEDICAL MYCOLOGY (2010)
Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection
Alexandra L. Quittner et al.
CHEST (2009)
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
George Z. Retsch-Bogart et al.
CHEST (2009)
Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis - a review
Marc Pihet et al.
MEDICAL MYCOLOGY (2009)
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
P. M. Gustafsson et al.
THORAX (2008)
Exacerbations in cystic fibrosis center dot 1: Epidemiology and pathogenesis
Christopher H. Goss et al.
THORAX (2007)
Cystic fibrosis: a polymicrobial infectious disease
Christopher D. Sibley et al.
FUTURE MICROBIOLOGY (2006)
Development and validation of the cystic fibrosis questionnaire in the United States - A health-related quality-of-life measure for cystic fibrosis
AL Quittner et al.
CHEST (2005)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference
DA Stevens et al.
CLINICAL INFECTIOUS DISEASES (2003)
Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis
B Cimon et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Share Paper
